Reminder: Invitation to Roche’s Virtual Pharma Day - Tuesday, 14th September 2021

Investor Update Reminder: Invitation to Roche's Virtual Pharma Day - Tuesday, 14th September 2021

The Roche Investor Relations team would like to invite you to Roche's Virtual Pharma Day 2021 that will take place as a live webinar on Tuesday, 14th September 2021 14:00 - 17:00 CEST / 13:00 - 16:00 BST 8:00 - 11:00 am EDT / 5:00 - 8:00 am PDT The webinar will start with presentations, followed by a Q&A session. Pharma strategy, Culture and organization, New technologies Market opportunities, Launches, Commercial model & Access Late stage pipeline: Oncology, Neuroscience, Immunology, Ophthalmology, Infectious diseases Presenters: Bill Anderson, Chief Executive Officer Roche Pharmaceuticals Teresa Graham, Head of Pharma Global Product Strategy Levi Garraway, Chief Medical Officer and Head Global Product Development Paulo Fontoura, Global Head of Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases, Clinical Development Nilesh Mehta, Life Cycle Leader Faricimab Barry Clinch, Global HeadInfectious Diseases, Clinical Development We would like to invite all interested parties to participate in the webinar and to pre-register here.* Should you be unable to register for the webinar due to your company IT policy, please send an email to [e-mail]. A replay of the event will be available via >ir.roche.com *privacy notice
Best regards, Karl Mahler Head of Investor Relations	Bruno Eschli Investor Relations Officer
Roche Investor Relations
Dr. Karl Mahler Phone: [phone] e-mail: [e-mail]	Jon Kaspar Bayard Phone: [phone] e-mail: [e-mail]
Dr. Sabine Borngräber Phone: [phone] e-mail: [e-mail]	Dr. Bruno Eschli Phone: [phone] e-mail: [e-mail]
Dr. Birgit Masjost Phone: [phone] e-mail: [e-mail]	Dr. Gerard Tobin Phone: [phone] e-mail: [e-mail]
Investor Relations North America
Loren Kalm Phone: [phone] e-mail: [e-mail]